Covidien Receives FDA Clearance to Market SILS(TM) Port Multiple Instrument Access Port

New Device Will Enable SILS(TM) Procedures
NORTH HAVEN, Conn., Jan. 8, 2009--(HSMN NewsFeed)--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced that its Surgical Devices business unit has received 510(k) clearance from the U.S. Food and Drug Administration to market the Covidien SILS(TM) Port Multiple Instrument Access Port for laparoscopic surgeries through a single incision.
The SILS(TM) Port is a single, flexible port that can be fitted through a small incision in the umbilicus which results in a single "hidden scar," a cosmetic advance over the multiple visible scars associated with standard multi-port laparoscopy. The port has the capacity for up to three laparoscopic instruments.

Full text >>